1. Medtech Insight
  2. >>Business

Starts & Stops: Medtronic's TMVR News Closes Big Month For Trial Announcements

 
• By Reed Miller

Starts & Stops is a regular feature highlighting Medtech Insight editors' picks of noteworthy medtech clinical trial announcements, initiations, completions, and suspensions each month. This month's edition, covering a long list of device trial updates that occurred between Sept. 24 and Oct. 31, is headlined by Medtronic's APOLLO US pivotal trial of the Intrepid transcatheter mitral valve.

Clinical Trial
• Source: shutterstock.com

Medtronic PLC launched the 1,200-patient APOLLO US trial of the Intrepid transcatheter mitral valve replacement system, the first-ever pivotal trial of a transcatheter mitral valve replacement system, a week before presenting encouraging data from the Intrepid pilot trial.

On Oct. 23, Medtronic announced the completion of the first implant in APOLLO trial following receipt of an investigational device exemption (IDE) from US FDA

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D